Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04215289 Completed - Clinical trials for Qnox Values as a Predictor of Pain Response

Compatibility of Qnox Values With Hemodynamic Changes in Tracheal Intubation Procedures

Start date: November 26, 2019
Phase:
Study type: Observational

The study aimed to analyze the compatibility of Qnox values with hemodynamic changes as a predictor of pain response in tracheal intubation procedures

NCT ID: NCT04215198 Completed - Clinical trials for Exercise-induced Joint Pain

NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Move3
Start date: September 20, 2018
Phase: N/A
Study type: Interventional

This study is intended to evaluate the effect of the dietary supplement combination of NEM® brand eggshell membrane + KD PUR® brand fish oil versus placebo in reducing exercise-induced joint pain, stiffness & cartilage turnover in healthy men & women. Half of the study participants will receive NEM + fish oil, once daily, orally while the other half of the study participants will receive placebo, once daily, orally while performing an exercise regimen every other day for two weeks.

NCT ID: NCT04214743 Completed - Sepsis Clinical Trials

Ocular Microvascular Changes in Patients With Sepsis

Start date: January 2, 2018
Phase:
Study type: Observational

This study evaluates differences in the ocular microcirculation between septic patients and healthy subjects and the course of ocular microvasculature in survivors and non-survivors over a 24 hours period of time in septic patients

NCT ID: NCT04214665 Completed - Clinical trials for Peripheral (Sensorimotor) Diabetic Polyneuropathy

To Assess the Bioequivalence of Test Oral Formulation of Alpha Lipoic Acid 600 mg HR Film Coated Tablets of Ilko Ilac San. Ve Tic. A.S. Versus Reference Thioctacid (Alpha Lipoic Acid) 600 mg HR Film Coated Tablets of Meda Pharma GmbH& CO .KG, Germany.

Start date: December 30, 2014
Phase: Phase 1
Study type: Interventional

To assess the bioequivalence of test oral formulation of Alpha Lipoic acid 600 mg HR film coated tablets of Ilko Ilac San. Ve Tic. A.S. versus reference Thioctacid (Alpha Lipoic acid) 600 mg HR film coated tablets of Meda Pharma GmbH& CO .KG, Germany.

NCT ID: NCT04214405 Completed - Clinical trials for Assessment of Proper Union of Fractures

One Point Versus Two Point Fixation of Tripodal Zygomatic Fractures

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The zygomatic bone defines the anterior and lateral projection of the face and articulates with the frontal, sphenoid,temporal, and maxillary bones. The zygomatic complex is responsible for the protection of the orbital contents and the mid-facial contour. Fracture of the zygomatic complex is one of the most common facial injuries in maxillofacial trauma and predominately appears in young adult males. The etiology of zygomatic complex fractures primarily includes road traffic accidents, violent assaults, falls and sports injuries. The main clinical features of zygomatic complex fractures include diplopia, enophthalmos, subconjunctival ecchymosis, extraocular muscle entrapment, cosmetic deformity with depression of the malar eminence, malocclusion and neurosensory disturbances of the infraorbital nerve. Diagnosis of zygomatic complex fractures is usually clinical with confirmation by computed tomography (CT) scan. Zygomatic complex fractures with no or minimal displacement are often treated without surgical intervention, whereas fractures with functional or esthetic impairments often necessitate surgical intervention. Various surgical approaches and treatment strategies have been proposed to obtain successful treatment outcome, including the Gilles temporal approach, eyebrow, upper eyelid, transconjunctival, infraciliary lower eyelid, and intraoral vestibular approaches. The surgical approach for adequate reduction of zygomatic complex fractures must ensure a good functional and cosmetic result. Surgical reduction of zygomatic fractures by an intraoral surgical approach was first described in1909 by Keen, and several studies have subsequently documented the treatment outcome after open reduction of zygomatic complex fractures by an intraoral surgical approach.

NCT ID: NCT04213339 Completed - Clinical trials for Urinary Incontinence in Geriatric Population

Effectiveness of Kegal Exercises on Urinary Incontinence Impact in Geriatric Incontinence

Start date: January 3, 2020
Phase: N/A
Study type: Interventional

This research study was used to determine effectiveness of kegal exercise on urinary incontinence impact in geriatric incontinence. There were two groups, One group was experimental which was subjected to Kegel exercises while other was control group without any treatment.

NCT ID: NCT04213092 Completed - Clinical trials for Choledocholithiasis With Cholecystitis With Obstruction

Single Setting ERCP and Laparoscopic Cholecystectomy is a Safe Procedure in Patients With Cholecysto-Choledocholithiasis

Start date: November 2012
Phase:
Study type: Observational

The ideal management of cholecysto-choledocholithiasis is an open cholecystectomy (OC) with the common bile duct (CBD) exploration worldwide. The single setting 2-stage approach- endoscopic retrograde cholangiopancreatography (ERCP), endoscopic sphincterotomy (EST), and CBD clearance followed by laparoscopic cholecystectomy (LC) offers an advantage, mainly by reducing the hospital stay, the cost, and the morbidity. Investigators did a prospective study in patients admitted for the management of the cholecysto-choledocholithiasis in the Department of Surgery at the Lumbini Medical College and Teaching Hospital from November 2012- October 2015. They underwent 2-stage ERCP+LC in a single setting and investigators compared them with 2-stage OC+CBD exploration in a single setting approach. The patients with the open procedure were the investigator's control groups. All the included cases in the study were elective.

NCT ID: NCT04213079 Completed - Clinical trials for Mal de Debarquement Syndrome (MdDS)

Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage

Start date: June 15, 2020
Phase: N/A
Study type: Interventional

Mal de Debarquement Syndrome (MdDS) is an under-recognized but nevertheless common balance disorder, which in most cases occurs after exposure to prolonged passive motion. The current treatment approaches focus on reducing symptoms, but they can be retriggered. This project aims to shift the focus of MdDS treatment to permanently eliminating the symptom trigger while also minimizing symptoms.

NCT ID: NCT04212117 Completed - Communication Clinical Trials

CALS Patient Activated Learning System (PALS)

Start date: February 18, 2020
Phase: N/A
Study type: Interventional

The overall goal in this line of inquiry is to test whether the Patient Activated Learning System (PALS) is effective in reducing disparities in access to reliable, easily understood health information, and whether this increased understanding has downstream consequences such as increases in trust in the medical system and self-management behaviors.

NCT ID: NCT04211831 Completed - Clinical trials for Overactive Bladder With Urge Urinary Incontinence

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

Start date: December 16, 2019
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy, safety, and tolerability of a single dose of URO-902 24 milligrams (mg) and 48 mg (administered via intradetrusor injection), compared with placebo, in participants with overactive bladder (OAB) and urge urinary incontinence (UUI) up to 48 weeks post-dose.